FENC
NASDAQ · Biotechnology
Fennec Pharmaceuticals Inc
$9.24
+2.47 (+36.48%)
Open$7.20
Previous Close$6.77
Day High$9.64
Day Low$7.20
52W High$9.92
52W Low$5.65
Volume—
Avg Volume368.5K
Market Cap334.98M
P/E Ratio—
EPS$-0.33
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+222.5% upside
Current
$9.24
$9.24
Target
$29.80
$29.80
$21.84
$29.80 avg
$37.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 56.63M | 74.30M | 77.18M |
| Net Income | -12,358,661 | -6,101,542 | -7,191,772 |
| Profit Margin | -21.8% | -8.2% | -9.3% |
| EBITDA | -10,535,133 | -9,610,170 | -10,191,915 |
| Free Cash Flow | — | -4,689,819 | -4,353,916 |
| Rev Growth | +207.2% | -7.2% | -5.1% |
| Debt/Equity | — | 0.51 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |